Influenza Virus Split Vaccine (Adjuvant)

· Changchun BCHT Biotechnology Co.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Influenza Virus Split Vaccine (Adjuvant), covering 2026-01-16 to 2026-01-16. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Trial to Evaluate the Safety and Immunogenicity of Influenza Virus Split Vaccine (Adjuvant) [Phase 1]